Pfizer Inc (NYSE:PFE)

35.27
Delayed Data
As of Apr 24
 -0.09 / -0.25%
Today’s Change
27.51
Today|||52-Week Range
35.53
+13.23%
Year-to-Date
Are Biosimilars the Next Big Thing in Biotech?
Apr 25 / MotleyFool.com
Targacept's Diabetic Gastroparesis Drug Fails to Impress - Analyst Blog
Apr 17 / Zacks.com
The Parade of Weak Earnings Reports Continues - Earnings Preview
Apr 24 / Zacks.com
Pfizer's Ibrance Study Stopped Early on Favorable Data - Analyst Blog
Apr 16 / Zacks.com
Frontrunning: April 24
Apr 24 / Investing Channel
The Zacks Analyst Blog Highlights: Pfizer, Pharmacyclics, Geron, Anthera Pharmaceutic...
Apr 16 / Zacks.com
Lazard revenues ride dealmaking wave
Apr 23 / FT.com
3 Biotech Stocks Under $10 with Amazing Growth Prospects - Analyst Blog
Apr 15 / Zacks.com
Pfizer's Cancer Drug Meets First Primary Endpoint in Phase III - Analyst Blog
Apr 22 / Zacks.com
Mylan Settles Patent Litigation Related to Pfizer's Viagra - Analyst Blog
Apr 14 / Zacks.com
Gilead May Be the Cure for the Blues
Apr 22 / TheStreet.com
2 Speculative Biotechs That Could Be Well Worth the Risk
Apr 14 / MotleyFool.com
Gilead May Be the Cure for the Blues
Apr 22 / TheStreet.com
Biotech: Making sense of the science
Apr 13 / FT.com
Is Immuno-Oncology the Best Area of Biotech to Invest in Right Now?
Apr 22 / MotleyFool.com
Stock Market News for April 13, 2015 - Market News
Apr 13 / Zacks.com
Are Buyback ETFs Worth Buying?
Apr 21 / Investing Channel
3 Best Dividend Stocks in Healthcare
Apr 12 / MotleyFool.com
Merck KGaA-Pfizer Start First Cancer Registration Study - Analyst Blog
Apr 21 / Zacks.com
Robey Warshaw makes the big league with role in BG sale
Apr 09 / FT.com
Pfizer Phase 3 Study Of Inotuzumab Ozogamicin Meets Primary Endpoint In Adult Patient...
Apr 21 / Benzinga
Big pharma turns to small biotechs for edge in cancer treatment
Apr 07 / FT.com
Global & Strategic Partners Initiate Phase III Study with Avelumab in Patients with S...
Apr 20 / Benzinga
UK reprieve for three cancer drugs
Apr 05 / FT.com
3 Megatrends in Healthcare
Apr 19 / MotleyFool.com
Pfizer halts China vaccine sales after import license not renewed
Apr 03 / FT.com
Future UK Labour government will give workers a say on the boss's pay
Apr 19 / FT.com
Healthcare sector leads feverish M&A activity
Mar 30 / FT.com
Targacept's Diabetic Gastroparesis Drug Fails to Impress - Analyst Blog
Apr 17 / Zacks.com
19 stocks to buy now
Mar 27 / CNNMoney.com

To view my watchlist

Not a member yet?

Sign up now for a free account